GSCLX
Price
$33.91
Change
+$0.10 (+0.30%)
Updated
Dec 2 closing price
Net Assets
1.64B
RGACX
Price
$85.71
Change
+$0.36 (+0.42%)
Updated
Dec 2 closing price
Net Assets
340.05B
Interact to see
Advertisement

GSCLX vs RGACX

Header iconGSCLX vs RGACX Comparison
Open Charts GSCLX vs RGACXBanner chart's image
Goldman Sachs Large Cap Gr Insghts Svc
Price$33.91
Change+$0.10 (+0.30%)
VolumeN/A
Net Assets1.64B
American Funds Growth Fund of Amer R3
Price$85.71
Change+$0.36 (+0.42%)
VolumeN/A
Net Assets340.05B
GSCLX vs RGACX Comparison Chart in %
View a ticker or compare two or three
VS
GSCLX vs. RGACX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSCLX is a Buy and RGACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 340B vs. GSCLX (1.64B). RGACX pays higher dividends than GSCLX: RGACX (0.07) vs GSCLX (0.00). GSCLX was incepted earlier than RGACX: GSCLX (29 years) vs RGACX (24 years). GSCLX (1.09) is less costly to investors than RGACX (0.94). GSCLX is a more actively managed with annual turnover of: 215.00 vs. RGACX (25.00). GSCLX has a lower initial minimum investment than RGACX: GSCLX (0) vs RGACX (250). RGACX annual gain was more profitable for investors over the last year : 6.46 vs. GSCLX (2.15). RGACX return over 5 years is better than : 29.83 vs. GSCLX (-16.76).
GSCLXRGACXGSCLX / RGACX
Total Expense Ratio1.060.94113%
Annual Report Gross Expense Ratio1.090.94116%
Fund Existence29 years24 years-
Gain YTD15.00018.55881%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.64B340B0%
Annual Yield % from dividends0.000.07-
Returns for 1 year2.156.4633%
Returns for 3 years34.8060.0958%
Returns for 5 years-16.7629.83-56%
Returns for 10 years47.2989.9053%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEPH5.430.20
+3.80%
Nephros
WTFCN26.34-0.03
-0.11%
Wintrust Financial Corp
HSIC71.65-1.46
-2.00%
Henry Schein
PTLO4.94-0.14
-2.76%
Portillo's
NRIX16.35-0.56
-3.31%
Nurix Therapeutics